Attenuation of hyperinsulinemia in polycystic ovary syndrome: What are the options?

被引：0
|
作者：
Ehrmann, DA [1 ]
机构：
[1] Univ Chicago, Pritzker Sch Med, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA
来源：
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 1998年 / 21卷 / 09期
关键词：
PCOS; insulin resistance; metformin; troglitazone;
D O I：
10.1007/BF03350790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：632 / 635
页数：4
相关论文
共 50 条
  • [31] Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity
    Mather, KJ
    Kwan, F
    Corenblum, B
    FERTILITY AND STERILITY, 2000, 73 (01) : 150 - 156
  • [32] The role of hyperinsulinemia as a cardiometabolic risk factor independent of obesity in polycystic ovary syndrome
    Csenteri, Orsolya Karola
    Sandor, Janos
    Kalina, Edit
    Bhattoa, Harjit Pal
    Godeny, Sandor
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (01) : 34 - 38
  • [33] Pharmacological modulation of insulin resistance and hyperinsulinemia in polycystic ovary syndrome: The emerging role
    Verma, S
    Mather, K
    Dumont, AS
    Anderson, TJ
    ENDOCRINOLOGIST, 1998, 8 (06): : 418 - 424
  • [34] 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome
    Guducu, Nilgun
    Gormus, Uzay
    Kutay, Salih Serdar
    Kavak, Zehra Nese
    Dunder, Ilkkan
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (08) : 557 - 560
  • [35] HYPERINSULINEMIA IN THE POLYCYSTIC-OVARY-SYNDROME CONFIRMED WITH A SPECIFIC IMMUNORADIOMETRIC ASSAY FOR INSULIN
    CONWAY, GS
    CLARK, PMS
    WONG, D
    CLINICAL ENDOCRINOLOGY, 1993, 38 (02) : 219 - 222
  • [36] Hyperinsulinemia in the polycystic ovary syndrome: A clinical, endocrine and echographic study in 240 patients
    Falsetti, L
    Eleftheriou, G
    GYNECOLOGICAL ENDOCRINOLOGY, 1996, 10 (05) : 319 - 326
  • [37] Polycystic ovary syndrome in adolescents: Current and future treatment options
    Mastorakos G.
    Lambrinoudaki I.
    Creatsas G.
    Pediatric Drugs, 2006, 8 (5) : 311 - 318
  • [38] Conservative treatment options for polycystic ovary syndrome: the importance of exercise
    Liska, D.
    Zahumensky, J.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2020, 85 (06): : 430 - 435
  • [39] Polycystic ovary syndrome: Metabolic challenges and new treatment options
    Bachmann, GA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (06) : S87 - S88
  • [40] What are the key features of importance in polycystic ovary syndrome?
    Lobo, RA
    FERTILITY AND STERILITY, 2003, 80 (02) : 259 - 261
12345